Dual antiplatelet therapy with ticagrelor and acetylsalicylic acid (ASA) vs. ASA only after isolated coronary artery bypass grafting in patients with acute coronary syndrome (TACSI trial)
Latest Information Update: 25 Sep 2024
At a glance
- Drugs Ticagrelor (Primary) ; Aspirin
- Indications Cardiovascular disorders; Myocardial infarction; Stroke
- Focus Therapeutic Use
- Acronyms TACSI trial
- 06 Sep 2024 Planned End Date changed from 1 Jun 2031 to 15 Mar 2035.
- 06 Sep 2024 Planned primary completion date changed from 1 Jun 2025 to 15 Mar 2025.
- 06 Sep 2024 Status changed from recruiting to active, no longer recruiting.